Evolent Health waives lock-up restrictions to allow Magellan Health to sell its EVH shares to institutional fund manager

Evolent Health, Inc.

Magellan Health agreed to sell its EVH Class A common stock to funds managed by an institutional fund manager with existing EVH investments.
Evolent Health waived all restrictions in the Lock Up Agreement dated Jan 20, 2023 to permit the sale.
The Lock Up Agreement will terminate upon closing of the sale.
No financial terms of the sale were disclosed.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.